Business Description
Fortrea Holdings Inc
NAICS : 541715
SIC : 2834
ISIN : US34965K1079
Share Class Description:
FRA:K67: When IssueTotal Employee Number:
14,000Description
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.2 | |||||
Debt-to-Equity | 2.13 | |||||
Debt-to-EBITDA | -3.98 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.28 | |||||
Beneish M-Score | -3.13 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.4 | |||||
3-Year EPS without NRI Growth Rate | -39.9 | |||||
3-Year FCF Growth Rate | 44.6 | |||||
3-Year Book Growth Rate | -45.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 41.64 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.07 | |||||
9-Day RSI | 61.43 | |||||
14-Day RSI | 64.37 | |||||
3-1 Month Momentum % | 38.85 | |||||
6-1 Month Momentum % | -26.35 | |||||
12-1 Month Momentum % | 152.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.95 | |||||
Quick Ratio | 0.95 | |||||
Cash Ratio | 0.16 | |||||
Days Sales Outstanding | 22.68 | |||||
Days Payable | 11.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | 3.4 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 18.86 | |||||
Operating Margin % | -0.09 | |||||
Net Margin % | -16.5 | |||||
EBITDA Margin % | -10.37 | |||||
FCF Margin % | 6.97 | |||||
OCF Margin % | 8.09 | |||||
ROE % | -71.66 | |||||
ROA % | -15.85 | |||||
ROIC % | -0.1 | |||||
3-Year ROIIC % | 14.13 | |||||
ROC (Joel Greenblatt) % | -238.41 | |||||
ROCE % | -19.1 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 20.83 | |||||
PE Ratio without NRI | 31.88 | |||||
PS Ratio | 0.61 | |||||
PB Ratio | 3.21 | |||||
Price-to-Free-Cash-Flow | 8.81 | |||||
Price-to-Operating-Cash-Flow | 7.59 | |||||
EV-to-EBIT | -7.4 | |||||
EV-to-Forward-EBIT | -98.48 | |||||
EV-to-EBITDA | -9.47 | |||||
EV-to-Forward-EBITDA | 48.34 | |||||
EV-to-Revenue | 0.98 | |||||
EV-to-Forward-Revenue | 1.02 | |||||
EV-to-FCF | 13.96 | |||||
Price-to-GF-Value | 0.98 | |||||
Earnings Yield (Greenblatt) % | -13.51 | |||||
FCF Yield % | 11.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fortrea Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,327.977 | ||
| EPS (TTM) (€) | -4.249 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 124.21 | ||
| 14-Day RSI | 64.37 | ||
| 14-Day ATR (€) | 0.388784 | ||
| 20-Day SMA (€) | 13.91 | ||
| 12-1 Month Momentum % | 152.31 | ||
| 52-Week Range (€) | 3.68 - 15.4 | ||
| Shares Outstanding (Mil) | 94.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fortrea Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fortrea Holdings Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 08:00 | In 121 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 120 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 08:00 | In 30 days | ||
| Second quarter earnings results for 2026 | 2026-08-06 | In 29 days | ||
| General meeting for 2026 | 2026-06-09 08:00 | 10.90 (+0.00%) | ||
| Jefferies Global Healthcare Conference (NYC) | 2026-06-04 08:45 | 10.90 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-05 08:00 | 10.10 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-05 | 10.10 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 08:00 | 8.80 (+2.92%) | ||
| Annual report for 2025 | 2026-02-26 | 8.80 (+2.92%) |
Show
Entries
Fortrea Holdings Inc Frequently Asked Questions
What is Fortrea Holdings Inc(FRA:K67)'s stock price today?
The current price of FRA:K67 is €14.60. The 52 week high of FRA:K67 is €15.40 and 52 week low is €3.68.
When is next earnings date of Fortrea Holdings Inc(FRA:K67)?
The next earnings date of Fortrea Holdings Inc(FRA:K67) is 2026-08-06 Est..
Does Fortrea Holdings Inc(FRA:K67) pay dividends? If so, how much?
Fortrea Holdings Inc(FRA:K67) does not pay dividend.
Press Release
Articles on Fortrea Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers